EUVIMEDDescoperă EUVIMED
Randomisierte kontrollierte StudieMultizentrische StudieOpen access · CC BY 4.0

Impact and timing of pulmonary rehabilitation in patients undergoing bronchoscopic lung volume reduction with endobronchial valves: A multicentre randomized controlled trial in patients with severe emphysema

Marieke C van der Molen iD, Rein Posthuma, Jorine E Hartman iD, Hester van der Vaart, Eline Bij de Vaate, Anouk W Vaes iD, Bram van den Borst, Dirk van Ranst, Martijn A Spruit iD, Lowie E G W Vanfleteren iD, Dirk-Jan Slebos, SoLVE consortium group

Respirology · 2024

DOI: 10.1111/resp.14734 ↗

At a glance

Randomisierte kontrollierte Studie in Respirology, 2024. Written by Marieke C van der Molen and 11 co-authors. Institution: Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Major MEDLINE topics: Bronchoscopy, Pneumonectomy, Pulmonary Emphysema, Exercise Tolerance. Cited 15 times so far (Crossref); 27 references. The full text is freely available (open access, CC BY 4.0). Funded by: Lung Foundation Netherlands.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background and Objective Both bronchoscopic lung volume reduction with endobronchial valves (BLVR‐EBV) and pulmonary rehabilitation (PR) are effective treatments for improving exercise capacity and patient‐reported outcomes in patients with severe Chronic Obstructive Pulmonary Disease (COPD). According to current recommendations, all BLVR‐EBV patients should have undergone PR first. Our aim was to study the effects of PR both before and after BLVR‐EBV compared to BLVR‐EBV alone.

Methods

We included patients with severe COPD who were eligible for BLVR‐EBV and PR. Participants were randomized into three groups: PR before BLVR‐EBV, PR after BLVR‐EBV or BLVR‐EBV without PR. The primary outcome was change in constant work rate cycle test (CWRT) endurance time at 6‐month follow‐up of the PR groups compared to BLVR‐EBV alone. Secondary endpoints included changes in 6‐minute walking test, daily step count, dyspnoea and health‐related quality of life.

Results

Ninety‐seven participants were included. At 6‐month follow‐up, there was no difference in change in CWRT endurance time between the PR before BLVR‐EBV and BLVR‐EBV alone groups (median: 421 [IQR: 44; 1304] vs. 787 [123; 1024] seconds, p = 0.82) or in any of the secondary endpoints, but the PR after BLVR‐EBV group exhibited a smaller improvement in CWRT endurance time (median: 107 [IQR: 2; 573], p = 0.04) and health‐related quality of life compared to BLVR‐EBV alone.

Conclusion

The addition of PR to BLVR‐EBV did not result in increased exercise capacity, daily step count or improved patient‐reported outcomes compared to BLVR‐EBV alone, neither when PR was administered before BLVR‐EBV nor when PR was administered after BLVR‐EBV.

Subjects

MeSH terms (MEDLINE)

BronchoscopyPneumonectomyPulmonary EmphysemaExercise ToleranceQuality of LifeHumansMaleFemaleAgedMiddle AgedTreatment OutcomeWalk TestPulmonary Disease, Chronic ObstructiveProstheses and ImplantsTime FactorsSeverity of Illness Index

Author keywords

Bronchoscopic lung volume reductionCOPDchronic obstructive pulmonary diseaseendobronchial valvespulmonary rehabilitation

Authors and institutions

  • Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Department of Respiratory Medicine, Maastricht University, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Department of Research and Development, Ciro, Horn, the Netherlands.
  • NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.
  • Center of Rehabilitation Beatrixoord, Haren, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

ORCID profiles: Marieke C van der Molen, Jorine E Hartman, Anouk W Vaes, Martijn A Spruit, Lowie E G W Vanfleteren

Funding

  • Lung Foundation Netherlands

Cite

APA

van der Molen, M. C., Posthuma, R., Hartman, J. E., van der Vaart, H., Bij de Vaate, E., Vaes, A. W., van den Borst, B., van Ranst, D., Spruit, M. A., Vanfleteren, L. E. G. W., Slebos, D. J., & SoLVE consortium group (2024). Impact and timing of pulmonary rehabilitation in patients undergoing bronchoscopic lung volume reduction with endobronchial valves: A multicentre randomized controlled trial in patients with severe emphysema. Respirology. https://doi.org/10.1111/resp.14734

Vancouver

van der Molen MC, Posthuma R, Hartman JE, van der Vaart H, Bij de Vaate E, Vaes AW, et al. Impact and timing of pulmonary rehabilitation in patients undergoing bronchoscopic lung volume reduction with endobronchial valves: A multicentre randomized controlled trial in patients with severe emphysema. Respirology. 2024. doi:10.1111/resp.14734

BibTeX
@article{vanderMolen2024,
  author = {van der Molen, Marieke C and Posthuma, Rein and Hartman, Jorine E and van der Vaart, Hester and Bij de Vaate, Eline and Vaes, Anouk W and van den Borst, Bram and van Ranst, Dirk and Spruit, Martijn A and Vanfleteren, Lowie E G W and Slebos, Dirk-Jan and SoLVE consortium group, SoLVE consortium group},
  title = {Impact and timing of pulmonary rehabilitation in patients undergoing bronchoscopic lung volume reduction with endobronchial valves: A multicentre randomized controlled trial in patients with severe emphysema},
  journal = {Respirology},
  year = {2024},
  doi = {10.1111/resp.14734}
}
Start for free →